Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enanta Pharmaceuticals Inc (NASDAQ:ENTA)

50.65
Delayed Data
As of Jul 31
 +1.01 / +2.03%
Today’s Change
30.13
Today|||52-Week Range
52.58
-0.39%
Year-to-Date

Today’s Trading

Previous close49.64
Today’s open51.00
Day’s range49.12 - 51.38
Volume242,960
Average volume (3 months)323,213
Market cap$946.7M
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+168.67%
Earnings growth (next 5 years)--
Revenue growth (last year)+48.94%
P/E ratio8.6
Price/Sales15.90
Price/Book6.34

Competitors

 Today’s
change
Today’s
% change
PDLIPDL BioPharma Inc+0.06+1.04%
FLMLFlamel Technologies ...+0.04+0.17%
EPZMEpizyme Inc-0.02-0.09%
ARNAArena Pharmaceutical...+0.07+1.76%
Data as of 3:59pm ET, 07/31/2015

Financials

Next reporting dateAugust 7, 2015
EPS forecast (this quarter)$0.23
Annual revenue (last year)$47.7M
Annual profit (last year)$34.4M
Net profit margin72.14%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jay R. Luly
Chief Financial Officer &
Senior VP-Administration
Paul J. Mellett
Corporate headquarters
Watertown, Massachusetts

Forecasts